XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Deferred Stock Units
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Balance beginning of period (in shares) at Dec. 31, 2022   107,193          
Balance beginning of period at Dec. 31, 2022 $ 608,737 $ 10,719 $ 1,463,215 $ 5,182 $ 3,599,529 $ (77,796) $ (4,392,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 214,054       214,054    
Other comprehensive (loss) income, net of tax 1,181         1,181  
Repurchases of common stock, net (9,554)           (9,554)
Common stock issued for share-based compensation plans, including excess tax benefit (in shares)   128          
Common stock issued for share-based compensation plans, including excess tax benefit 12,753 $ 13 12,765 (25)      
Share-based compensation cost 13,930   13,923 7      
Balance end of period (in shares) at Mar. 31, 2023   107,321          
Balance end of period at Mar. 31, 2023 841,101 $ 10,732 1,489,903 5,164 3,813,583 (76,615) (4,401,666)
Balance beginning of period (in shares) at Dec. 31, 2022   107,193          
Balance beginning of period at Dec. 31, 2022 608,737 $ 10,719 1,463,215 5,182 3,599,529 (77,796) (4,392,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 650,521            
Other comprehensive (loss) income, net of tax 2,905            
Balance end of period (in shares) at Sep. 30, 2023   107,452          
Balance end of period at Sep. 30, 2023 1,297,407 $ 10,745 1,543,024 5,523 4,250,050 (74,891) (4,437,044)
Balance beginning of period (in shares) at Mar. 31, 2023   107,321          
Balance beginning of period at Mar. 31, 2023 841,101 $ 10,732 1,489,903 5,164 3,813,583 (76,615) (4,401,666)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 224,236       224,236    
Other comprehensive (loss) income, net of tax 2,950         2,950  
Repurchases of common stock, net (77)           (77)
Common stock issued for share-based compensation plans, including excess tax benefit (in shares)   57          
Common stock issued for share-based compensation plans, including excess tax benefit 10,289 $ 6 9,938 345      
Share-based compensation cost 15,362   15,356 6      
Balance end of period (in shares) at Jun. 30, 2023   107,378          
Balance end of period at Jun. 30, 2023 1,093,861 $ 10,738 1,515,197 5,515 4,037,819 (73,665) (4,401,743)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 212,231       212,231    
Other comprehensive (loss) income, net of tax (1,226)         (1,226)  
Repurchases of common stock, net (35,301)           (35,301)
Common stock issued for share-based compensation plans, including excess tax benefit (in shares)   74          
Common stock issued for share-based compensation plans, including excess tax benefit 12,618 $ 7 12,611        
Share-based compensation cost 15,224   15,216 8      
Balance end of period (in shares) at Sep. 30, 2023   107,452          
Balance end of period at Sep. 30, 2023 $ 1,297,407 $ 10,745 1,543,024 5,523 4,250,050 (74,891) (4,437,044)
Balance beginning of period (in shares) at Dec. 31, 2023 107,506 107,506          
Balance beginning of period at Dec. 31, 2023 $ 1,484,530 $ 10,751 1,569,565 5,530 4,444,571 (71,206) (4,474,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 235,579       235,579    
Other comprehensive (loss) income, net of tax (9,191)         (9,191)  
Repurchases of common stock, net (177,192)           (177,192)
Common stock issued for share-based compensation plans, including excess tax benefit (in shares)   161          
Common stock issued for share-based compensation plans, including excess tax benefit 20,780 $ 16 20,792 (28)      
Share-based compensation cost 14,400   14,392 8      
Balance end of period (in shares) at Mar. 31, 2024   107,667          
Balance end of period at Mar. 31, 2024 $ 1,568,906 $ 10,767 1,604,749 5,510 4,680,150 (80,397) (4,651,873)
Balance beginning of period (in shares) at Dec. 31, 2023 107,506 107,506          
Balance beginning of period at Dec. 31, 2023 $ 1,484,530 $ 10,751 1,569,565 5,530 4,444,571 (71,206) (4,474,681)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 671,718            
Other comprehensive (loss) income, net of tax $ (4,765)            
Balance end of period (in shares) at Sep. 30, 2024 107,705 107,705          
Balance end of period at Sep. 30, 2024 $ 1,618,054 $ 10,770 1,646,363 5,885 5,116,289 (75,971) (5,085,282)
Balance beginning of period (in shares) at Mar. 31, 2024   107,667          
Balance beginning of period at Mar. 31, 2024 1,568,906 $ 10,767 1,604,749 5,510 4,680,150 (80,397) (4,651,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 203,298       203,298    
Other comprehensive (loss) income, net of tax (4,784)         (4,784)  
Repurchases of common stock, net (208,246)           (208,246)
Common stock issued for share-based compensation plans, including excess tax benefit (in shares)   19          
Common stock issued for share-based compensation plans, including excess tax benefit 5,360 $ 2 4,983 375      
Share-based compensation cost 15,719   15,719        
Balance end of period (in shares) at Jun. 30, 2024   107,686          
Balance end of period at Jun. 30, 2024 1,580,253 $ 10,769 1,625,451 5,885 4,883,448 (85,181) (4,860,119)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 232,841       232,841    
Other comprehensive (loss) income, net of tax 9,210         9,210  
Repurchases of common stock, net (225,163)           (225,163)
Common stock issued for share-based compensation plans, including excess tax benefit (in shares)   19          
Common stock issued for share-based compensation plans, including excess tax benefit 4,995 $ 1 4,994        
Share-based compensation cost $ 15,918   15,918        
Balance end of period (in shares) at Sep. 30, 2024 107,705 107,705          
Balance end of period at Sep. 30, 2024 $ 1,618,054 $ 10,770 $ 1,646,363 $ 5,885 $ 5,116,289 $ (75,971) $ (5,085,282)